ALLYNZA STUDY CELL-BASED ADJUVANT TECHNOLOGY

Welcome to the Brand page for “ALLYNZA STUDY CELL-BASED ADJUVANT TECHNOLOGY”, which is offered here for The mark consists of the wording allynza study above the wording cell-based adjuvant technology. to the left of the wording allynza study is a design of a circle with an arrow-like shape through the circle. the tip of the arrow is a design of a rocket ship. the wording allynza study is in the color purple. the rest of the wording in the mark is in the color gray. the circle element of the design is in the colors red and gray, and the arrow-like element of the design is red and purple with the rocket ship element being in the color purple.;the color(s) red, purple, and gray is/are claimed as a feature of the mark.;providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; and medical information;study cell-based adjuvant technology;providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development; providing information about pharmaceutical research and development;.

Its status is currently believed to be active. Its class is unavailable. “ALLYNZA STUDY CELL-BASED ADJUVANT TECHNOLOGY” is believed to be currently owned by “Seqirus Inc.”


Owner:
SEQIRUS INC.
Owner Details
Description:
The mark consists of the wording ALLYNZA STUDY above the wording CELL-BASED ADJUVANT TECHNOLOGY. To the left of the wording ALLYNZA STUDY is a design of a circle with an arrow-like shape through the circle. The tip of the arrow is a design of a rocket ship. The wording ALLYNZA STUDY is in the color purple. The rest of the wording in the mark is in the color gray. The circle element of the design is in the colors red and gray, and the arrow-like element of the design is red and purple with the rocket ship element being in the color purple.;The color(s) red, purple, and gray is/are claimed as a feature of the mark.;Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; and medical information;STUDY CELL-BASED ADJUVANT TECHNOLOGY;Providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development; Providing information about pharmaceutical research and development;
Categories: